The 3D Bioprinter of Prometheus guarantees a higher cell viability (>95%) after printer and beyond, instead of other machines (<65%) now available in different laboratories.
Thanks to the innovative extrusion system, we are able to control cell disposition inside the final tissue, creating functional tissue always equal one to another, even if created in different process. This aspect is really important to have more reliable data when 3D artificial tissues are used for drug testing.
Special Webinar: Thursday, 27 March 2025 at 3 p.m. Cosmetic active ingredients and products are…
Editor Tim Probert caught up with four participants - Anne Charpentier, CEO of Skinobs; Mike…
Mieke Meintjes 27 February 2025 Scientists at Florida International University and the University of Miami,…